# The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED)

> **NCT02649621** · PHASE1 · COMPLETED · sponsor: **Royan Institute** · enrollment: 10 (actual)

## Conditions studied

- Limbal Stem Cell Deficiency (LSCD)

## Interventions

- **BIOLOGICAL:** Amniotic Membrane Extract Eye Drop (AMEED)

## Key facts

- **NCT ID:** NCT02649621
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-03
- **Final completion:** 2012-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02649621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02649621, "The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02649621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*